Aquestive Therapeutics
AQST
#6338
Rank
$0.80 B
Marketcap
$6.62
Share price
3.76%
Change (1 day)
70.18%
Change (1 year)

Revenue for Aquestive Therapeutics (AQST)

Revenue in 2025 (TTM): $43.39 Million USD

According to Aquestive Therapeutics 's latest financial reports the company's current revenue (TTM ) is $43.39 Million USD. In 2024 the company made a revenue of $57.56 Million USD an increase over the revenue in the year 2023 that were of $50.58 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aquestive Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $43.39 M-24.61%
2024 $57.56 M13.8%
2023 $50.58 M6.09%
2022 $47.68 M-6.2%
2021 $50.83 M10.87%
2020 $45.84 M-12.85%
2019 $52.6 M-21.98%
2018 $67.43 M0.76%
2017 $66.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
$0.22 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$0.64 B 1,379.52%๐Ÿ‡บ๐Ÿ‡ธ USA